Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.22.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Cash flows from operating activities          
Net income (loss) $ 7,446 $ (1,395) $ 19,940 $ (338)  
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:          
Realized loss on marketable debt securities 7 5 186 7  
Depreciation and amortization     2,516 1,118  
Amortization of debt discount     2 3  
Amortization on operating lease right-of-use assets     168 167  
Loss on sale of assets     74  
Stock-based compensation expense     1,010 1,504  
Change in fair value of investment securities (164) 76 (164)  
Accounts receivable allowances     1,988  
Inventory valuation reserve     25  
Non-cash interest income on secured promissory note receivable     (315)  
Changes in operating assets and liabilities:          
Accounts receivable     (941) (3,466)  
Inventory     66 (12,130)  
Prepaid expenses and other current assets     104 2,434  
Deferred tax asset     (594)    
Other assets     (674) (8)  
Accounts payable     (2,583) 3,343  
Accrued diagnostic services     (1,130)  
Accrued advertising and other allowances     51  
Deferred revenue     474  
Operating lease liabilities     (147) 205  
Income tax payable     5,475  
Other current liabilities     (978) 4,190  
Net cash provided by (used in) operating activities     25,108 (3,450)  
Cash flows from investing activities          
Issuance of secured promissory note receivable     (1,000)  
Purchase of marketable securities     (607) (16,841)  
Proceeds from sale of marketable debt securities     5,600 300  
Proceeds from dispositions of property and other assets, net     372  
Capital expenditures     (1,769) (4,237)  
Net cash provided by (used in) investing activities     3,596 (21,778)  
Cash flows from financing activities          
Proceeds from issuance of common stock from public offering, net     35,135  
Proceeds from issuance of common stock and warrants from private offering     5,500  
Repayment of note payable     (1,444)  
Repurchases of common shares     (1,150)  
Payment of dividends     (9,351) (4,546)  
Repurchase of common stock for payment of statutory taxes due on cashless exercise of stock option     (1,458)  
Net cash (used in) provided by financing activities     (13,403) 36,089  
Increase in cash, cash equivalents and restricted cash     15,301 10,861  
Cash, cash equivalents and restricted cash, at the beginning of the period     8,658 6,816 $ 6,816
Cash, cash equivalents and restricted cash, at the end of the period $ 23,959 $ 17,677 23,959 17,677 $ 8,658
Supplemental disclosures:          
Cash paid for income taxes     1,500  
Interest payment on the promissory notes     441 500  
Supplemental disclosure of non-cash investing and financing activities:          
Issuance of common shares for debt conversion     600  
Net unrealized loss, investments in marketable debt securities     $ (61) $ (78)